These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 16890406

  • 21. MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus.
    Monk CR, Spachidou M, Rovis F, Leung E, Botto M, Lechler RI, Garden OA.
    Arthritis Rheum; 2005 Apr; 52(4):1180-4. PubMed ID: 15818683
    [Abstract] [Full Text] [Related]

  • 22. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [Abstract] [Full Text] [Related]

  • 23. Conserved anti-proliferative effect and poor inhibition of TNFalpha secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus.
    Gómez J, Prado C, López P, Suárez A, Gutiérrez C.
    Clin Immunol; 2009 Sep; 132(3):385-92. PubMed ID: 19540813
    [Abstract] [Full Text] [Related]

  • 24. Selective loss of the CD4+ inducers of suppressor T cell subsets (2H4+) in active systemic lupus erythematosus.
    Raziuddin S, Nur MA, Alwabel AA.
    J Rheumatol; 1989 Oct; 16(10):1315-9. PubMed ID: 2530345
    [Abstract] [Full Text] [Related]

  • 25. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH, Anderson M, Le E, La Cava A.
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 29. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.
    Slobodin G, Ahmad MS, Rosner I, Peri R, Rozenbaum M, Kessel A, Toubi E, Odeh M.
    Cell Immunol; 2010 Mar; 261(2):77-80. PubMed ID: 20096404
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 32. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH, Shen Q, Zhao DB, Cai Q, Han XH.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):318-23. PubMed ID: 15854508
    [Abstract] [Full Text] [Related]

  • 33. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics.
    Pool AJ, Whipp BJ, Skasick AJ, Alavi A, Bland JM, Axford JS.
    Rheumatology (Oxford); 2004 Jan 02; 43(1):43-8. PubMed ID: 12867581
    [Abstract] [Full Text] [Related]

  • 34. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.
    Liu Y, Zhu T, Cai G, Qin Y, Wang W, Tang G, Zhao D, Shen Q.
    Lupus; 2011 May 02; 20(6):620-7. PubMed ID: 21558138
    [Abstract] [Full Text] [Related]

  • 35. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA.
    Br J Dermatol; 2004 Apr 02; 150(4):693-700. PubMed ID: 15099365
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.
    Lee HY, Hong YK, Yun HJ, Kim YM, Kim JR, Yoo WH.
    Rheumatology (Oxford); 2008 Jun 02; 47(6):789-94. PubMed ID: 18388146
    [Abstract] [Full Text] [Related]

  • 38. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.
    Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E.
    Lupus; 2007 Jun 02; 16(7):489-96. PubMed ID: 17670847
    [Abstract] [Full Text] [Related]

  • 39. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 02; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 40. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH.
    J Immunol; 2009 Dec 01; 183(11):7602-10. PubMed ID: 19917691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.